Cullinan Oncology - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi CGEM

Cullinan Therapeutics (CGEM) is a leading developer of targeted antibodies for the therapy of solid tumors. Monitoring EBITDA_Co via the GURU.Markets system chart demonstrates profit dynamics, where the 0.00 metric confirms the current level. Patent protection of unique molecules will provide the issuer with pricing power in the future, while strict laboratory control guarantees the environmental safety of bio-waste production.

Cullinan Therapeutics Inc - Bathi operasional EBITDA CGEM (periode 23.11.2025 - 13.11.2026)

Cullinan Therapeutics, Inc. (CGEM) - rincian metrik lan laporan keuangan

- nilai pasar lan prakiraan target analis:

Rega bursa Cullinan Corp|CGEM - Target konsensus

- rincian nilai pasar emiten:

Nilai pasar Cullinan Therapeutics|CGEM - Rega Nyata Tumbas Perusahaan Kanthi Wutuh

- informasi kapitalisasi buku:

Rega Buku Saham Cullinan Therapeutics|CGEM - Kapitalisasi Buku|Rasio Kapitalisasi Pasar marang Nilai Buku cullinanoncology.com|CGEM - Aset Agregat Perusahaan

- indikator total utang lan likuiditas perusahaan:

Rasio Kabeh Utang marang Dana Pribadi Cullinan Therapeutics|CGEM - Utang jangka dawa marang modal|Tanggungan utang jangka cendhak marang ekuitas Cullinan Oncology|CGEM - Gunggung utang perusahaan|Utang-utang marang nilai buku Cullinan Therapeutics|CGEM - Kewajiban jangka dawa perusahaan|Gedhene kewajiban jangka cendhak Cullinan Therapeutics|Likuiditas darurat cullinanoncology.com

- rincian asil keuangan lan kelipatan valuasi:

CGEM - Bathi resik|Prakiraan bathi resik Cullinan Therapeutics|CGEM - Koefisien rega marang bathi|Pangali mangsa ngarep rega marang bathi cullinanoncology.com|CGEM - Pangali rega marang bathi tumrap wutah|Koefisien nilai perusahaan marang bathi operasional sadurunge panyusutan Cullinan Therapeutics|CGEM - Bathi operasional EBITDA|Bathi saben saham sajroning taun lumaku Cullinan Therapeutics|CGEM - Bathi resik saben saham (EPS TTM)|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan cullinanoncology.com|CGEM - Wutah bathi saben saham ing taun lumaku|Dinamika bathi saben saham sing diarepake ing taun ngarep Cullinan Therapeutics

- indikator pendapatan dodolan lan penghasilan bisnis:

CGEM - Pendapatan lan volume dodolan|Prakiraan volume dodolan Cullinan Corp|CGEM - Rasio rega marang pendapatan|Rega mangsa ngarep marang pendapatan Cullinan Therapeutics

Ringkesan analitik perusahaan:Cullinan Therapeutics

Produk merek Cullinan Therapeutics, Inc.

Cullinan Therapeutics (CGEM) is investing significant resources into proprietary modular oncology platforms, which necessitates strict cash flow management amid regulatory risks. The recorded EBITDA reflects the net cash result of daily operations excluding depreciation and amortization, allowing investors to assess the business's actual operational resilience and its ability to service its debt load.

Analisis pesaing Cullinan Therapeutics